BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Temozolomide

A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.

299+ PubMed studies analyzed · 12 RCTs · Evidence Score: 50.6

Research Domains

Temozolomide has been studied across 17 research domains including 🔬 Oncology, ⏳ Longevity & Aging, 🫁 Liver & Detox, ⚡ Energy & Fatigue, 🧠 Focus & Attention. The primary research focus is 🔬 Oncology with 80% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Temozolomide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Sulfamethoxazole
2 shared targets
Practolol
2 shared targets
Piracetam
2 shared targets
Methylprednisolone
2 shared targets
Morphine
2 shared targets
Codeine
2 shared targets
Equilin
2 shared targets
Indomethacin
2 shared targets
Rosmarinic
2 shared targets
2-Chloroadenosine
2 shared targets
Loading evidence profile...

This evidence profile for Temozolomide is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.